Elsevier announces Nutraceuticals title and updated edition of best-selling "Drug-Like Properties"

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has announced the publication of Nutraceuticals: Efficacy, Safety and Toxicity, a first-of-its-kind reference detailing the use and potential toxic effects of nutraceuticals and dietary supplements.

Elsevier also introduced the second edition of Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization, its comprehensive and valuable working handbook on all aspects of drug research, discovery, design, development and optimisation for scientists and students.

Edited by renowned Elsevier collaborator, Dr Ramesh Gupta, Nutraceuticals brings together all current knowledge regarding the potential toxic effects of nutraceuticals, herbal medicines, ayurvedic medicines, prebiotics, probiotics and adaptogens. This essential reference also looks at the judicious use of nutraceuticals, the best tools for their evaluation, and regulatory aspects from around the world. Download a sample chapter of Nutraceuticals here.

Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization, Second Edition is written by Li Di, an associate research fellow at Pfizer, and Edward Kerns, writer and consultant in Discovery ADME.

This valuable resource explores physiochemical properties, including solubility and permeability, as well as how compounds are absorbed, distributed and metabolized safely and stably. The second edition includes expanded coverage of pharmacokinetics fundamentals and effects. Download a sample chapter of Drug-Like Properties here.